We understand that starting a new medication can be daunting, and our team is dedicated to providing guidance and support to manage any potential side effects, such as nausea or gastrointestinal discomfort, ensuring a smooth transition for our patients
-Social determinants of health evaluations
Sometimes, adjusting the dose of tirzepatide or switching to a different therapy is necessary
In the TRIUMPH-4 Phase 3 trial, 39% of participants on the highest Retatrutide dose lost 30% or more of their body weight, and 24% lost 35% or more
doi: 10.1111/apt.2013.37.issue-11 26 LiuNAndoTIshiguroKMaedaOWatanabeOFunasakaKet al
Altintas stressed that The findings should be viewed as hypothesis-generating rather than practice-changing. The study suggests that semaglutide does not appear to increase fracture risk and may potentially reduce it, but randomized prospective studies with bone mineral density, bone turnover markers, and fracture endpoints will be needed before concluding that semaglutide has true bone-protective properties, he told us